Back to search

West Virginia University

Long term AMPK activation limits obesity induced muscle atrophy

Abstract

dc:description.abstract

The aim of this study was to identify obesity-induced alterations in regulatory mechanisms of skeletal muscle mass and how they would be altered with long term (8 weeks) AMPK-agonist treatment. 8 week old male, lean (L) wild type [body weight (BW) = 26.9 g] and ob/ob (O) [BW = 46.2 g] mice were fed an AMP kinase (AMPK) activator, beta-GPA (F), mixed at a 1% concentration within their food or normal chow as control (C) for 8 weeks. Following an overnight (12 hr) fast, all mice were sacrificed and the gastrocnemius complex was excised for analysis. Muscle mass was lower in the OC mice (121.08 +/- 9.3 mg) versus LC (158.4 +/- 5.6 mg). This corresponded with decreases in raptor associated with mTOR. Following treatment, western analysis of OF muscle lysates displayed increased AMPK and acetyl-CoA carboxylase phosphorylation compared with LC and OC mice. OC mice displayed higher activation of mammalian Target of Rapamycin (mTOR)-regulated signaling (S6K1, 4E-BP1, and GSK3), which was reciprocally altered after 8 weeks of beta-GPA feeding. These data show that long term (8 week) AMPK-agonist treatment can augment obesity-induced alterations in regulatory mechanisms of skeletal muscle mass through the normalization to lean levels of mTOR signaling.

Degree

thesis:*
Name thesis:degree_name
MS
Level thesis:degree_level
Thesis
Discipline thesis:degree_discipline
Exercise Physiology

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Drake, Joshua C.

Subjects

dc:subject × 2

Identifiers

dc:identifier.*

Chain of custody

source
Harvested from
West Virginia University
Base URL
researchrepository.wvu.edu/do/oai/
Last updated
2026-11-19
Source record
OAI-PMH GetRecord
citation

Drake, Joshua C.. Long term AMPK activation limits obesity induced muscle atrophy. Thesis thesis, https://doi.org/10.33915/etd.2992